Company DescriptionSabinsa, celebrating 30 years of dedicated service to the nutritional/dietary supplement industry this year, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals that are the primary ingredients in successful products worldwide. Sabinsa’s mission is to provide alternative and complementary natural products for human nutrition and well-being by bringing modern research to traditional Ayurvedic knowledge. In the last thirty years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded clinical studies in conjunction with prestigious institutions in support of these products. In concert with parent company Sami Labs, the company employs 1,000 people worldwide in ten manufacturing, R&D and distribution facilities. Additionally, botanical cultivation efforts undertaken by the organization now total nearly 40,000 acres to ensure sustainable supplies on its key products, as well as a notable reforestation project in India. Products intended for human consumption are certified Kosher and Halal.
Key Market AreasProducts containing Sabinsa’s high-quality, science-based ingredients are found in fine products throughout the world. Sabinsa has marketing offices in the USA, Australia, China, Europe, Japan, South Korea and South Africa. Sabinsa also has agents that represent its product line throughout South America and Far East Asia.
Major Products / Service OfferingsSabinsa has pioneered numerous herbal ingredients in the nutraceuticals market, many of which are the leading branded ingredients in several categories. Sabinsa’s Curcumin C3 Complex® is the most clinically studied turmeric extract in the world. Other popular ingredients include: BioPerine®, LactoSpore®, Promond™, Digezyme®, Sabeet®, Saberry®, Boswellin®, GarCitrin®, ZeaLutein®, ForsLean®, Bacopin®, and many others.
Emphasis on developing and bringing to market products with scientific and clinical substantiation is Sabinsa’s core business philosophy and is in large part responsible for fueling the company’s ongoing commercial success. Sabinsa has obtained several IND approved clinical protocols for its products from the FDA. With more than 120 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent beneficial nutrients for the world market. Presently Sabinsa owns close to 200 USA & International patents and has over 100 pending patent applications worldwide.
In addition to providing science-backed ingredients, Sabinsa’s specialized services include custom product development, technical support and testing lab facilities, assistance in clinical evaluation and protocol implementation. The Utah NSF GMP facility provides contract manufacturing services to develop bulk and packaged finished goods, in various delivery formats such as tablets, bi-layer tablets, and capsules, and intermediary services such as milling, blending, roll compacting, and granulation.
Sabinsa Corp.20 Lake Drive
East Windsor, NJ 08520, USA
Website:www.Sabinsa.comFounded in 1988
Key PersonnelDr. Muhammed Majeed, Founder & Chairman
Shaheen Majeed, President – Worldwide
Anurag Pande, PhD, VP Scientific Affairs
Asha Ramesh, VP Business Development